Yahoo
NasdaqCM - Delayed Quote USD

BioRestorative Therapies, Inc. (BRTX)

0.1480 +0.0043 (+2.99%)
At close: September 4 at 4:00:00 PM EDT
0.1498 +0.0018 (+1.22%)
After hours: September 4 at 7:49:25 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
357.8700
359.7000
401
145.8000
119.8000
Cost of Revenue
28.3200
23.8440
28.0720
0
--
Gross Profit
329.5500
335.8560
372.9280
145.8000
--
Operating Expense
14,554.8810
15,982.9880
11,928.1220
15,283.2410
18,983.3070
Operating Income
-14,225.3310
-15,647.1320
-11,555.1940
-15,137.4410
-18,863.5070
Net Non Operating Interest Income Expense
171.0780
266.2070
616.0770
552.2930
11.6500
Other Income Expense
3,003.1510
1,138.9500
1,959.7360
4,167.4440
5,629.5610
Pretax Income
-11,056.5810
-14,241.9750
-8,979.3810
-10,417.7040
-13,222.2960
Net Income Common Stockholders
-11,056.5810
-14,241.9750
-8,979.3810
-10,417.7040
-13,222.2960
Diluted NI Available to Com Stockholders
-11,056.5810
-14,241.9750
-8,979.3810
-10,417.7040
-13,222.2960
Basic EPS
-1.06
-1.58
-1.16
-2.47
-3.65
Diluted EPS
-1.06
-1.58
-1.16
-2.47
-3.65
Basic Average Shares
11,335.7660
8,993.1150
7,763.9320
4,218.3470
3,617.8580
Diluted Average Shares
11,335.7660
8,993.1150
7,763.9320
4,218.3470
3,617.8580
Total Operating Income as Reported
-14,225.3310
-15,647.1320
-11,555.1940
-15,220.7740
-18,974.0250
Total Expenses
14,583.2010
16,006.8320
11,956.1940
15,283.2410
18,983.3070
Net Income from Continuing & Discontinued Operation
-11,056.5810
-14,241.9750
-8,979.3810
-10,417.7040
-13,222.2960
Normalized Income
-14,037.8020
-15,363.4770
-10,788.2670
-14,415.4840
-18,744.7690
Interest Income
171.0780
266.2070
616.0770
552.2930
11.6500
Net Interest Income
171.0780
266.2070
616.0770
552.2930
11.6500
EBIT
-14,225.3310
-15,647.1320
-11,555.1940
-15,137.4410
-18,863.5070
EBITDA
-14,014.7330
-15,437.1470
-11,366.1380
-14,971.7060
-18,742.9620
Reconciled Cost of Revenue
28.3200
23.8440
28.0720
0
--
Reconciled Depreciation
210.5980
209.9850
189.0560
165.7350
120.5450
Net Income from Continuing Operation Net Minority Interest
-11,056.5810
-14,241.9750
-8,979.3810
-10,417.7040
-13,222.2960
Total Unusual Items Excluding Goodwill
2,981.2210
1,121.5020
1,808.8860
3,997.7800
5,522.4730
Total Unusual Items
2,981.2210
1,121.5020
1,808.8860
3,997.7800
5,522.4730
Normalized EBITDA
-16,995.9540
-16,558.6490
-13,175.0240
-18,969.4860
-24,265.4350
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 12/5/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: